the one with proportion of ER-positive patients < 50%; the one in which trastuzumab was given to all patients), meta-regression analyses suggested that the between-subgroup differences did not reach statistical significance ( Table 2 ).
← all excerpts
The prognostic value of phosphorylated Akt in breast cancer: a systematic review.
1
—
—